Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions

By sjmartinez • August 8, 2024

Ljubimova JY, Holler E, Black KL, Ljubimov AV. Nanoparticles crossing blood-brain barrier need specific design for normal, neurodegenerative or cancerous brain conditions. Nanomedicine (Lond). 2024 Aug 7:1-4. doi: 10.1080/17435889.2024.2380241. Epub ahead of print. PMID: 39109486.

Tags: Alzheimer's and tumor, BBB, blood brain barrier (BBB), Blood-brain-barrier, Cedars Sinai DoM, cell-specific drug delivery, central nervous system, CNS immunity, diabetic retinopathy, Endocrinology, multifunctional nanoparticles, normal, peptides, Publications

Bioactive Lipids of Cardiorespiratory Fitness Insights From Exercise Models in Humans, Mice, and Burmese Pythons

Guseh JS, Roshandelpoor A, Alotaibi M, Zarbafian S, Lau ES, Kuznetsov A, Rosenzweig A, Saeidi N, Choudhary A, Jain M, Cheng S, Lewis GD, Ho[...]

Improved plaque composition from intensive medical treatment in women with angina and non-obstructive coronary disease

Lenell J, Flores Tomasino G, Han D, Wolny R, Park C, Grodecki K, Kwiecinski J, Xing E, Manral N, Asebiomo F, Goyal D, Calsavara VF,[...]

Mechanical Thrombectomy Versus Anticoagulation Alone in Intermediate-High Risk PE: Improved Functional 90-Day Outcomes in STORM-PE RCT

Rosovsky RP, Konstantinides SV, Weinberg I, Dohad SY, Rosol Z, Stępniewski J, Moriarty JM, Parikh SA, Holden A, Channick RN, McDonald B, Nagarsheth KH, Matusov[...]